|Articles|January 13, 2020
Ergomed Acquires Ashfield Pharmacovigilance Inc.
Advertisement
Ergomed plc has announced the acquisition of Ashfield Pharmacovigilance Inc. from UDG Healthcare US Holdings, Inc. Ergomed has acquired the entire issued share capital of Ashfield PV for a total cash consideration of $10 million.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When AI Learns to Speak Every Language: An eCOA Migration Study
2
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
3
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
4
Integrating Trials into Routine Care
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
